Build with KISHO Sign In Sign Up

Kisho

Serono, Inc. — Rare Disease Pipeline | Kisho | Kisho

Serono, Inc.

Other

3

Orphan Designations

0

FDA Approvals

15

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
gingival fibromatosis-progressive deafness syndrome	Novantrone	Orphan Designation	-
growth hormone insensitivity syndrome	Novantrone	Orphan Designation	-
growth hormone-producing pituitary gland adenoma	Novantrone	Orphan Designation	-
hereditary hypophosphatemic rickets with hypercalciuria	Novantrone	Orphan Designation	-
hormone receptor-positive breast cancer	Novantrone	Orphan Designation	-
hormone-resistant breast carcinoma	Novantrone	Orphan Designation	-
hormone-resistant prostate carcinoma	Novantrone	Orphan Designation	-
myopathy, reducing body, X-linked, childhood-onset	Novantrone	Orphan Designation	-
myopathy, reducing body, X-linked, early-onset, severe	Novantrone	Orphan Designation	-
progressive familial intrahepatic cholestasis	Novantrone	Orphan Designation	-
progressive relapsing multiple sclerosis	Novantrone	Orphan Designation	-
progressive supranuclear palsy	Novantrone	Orphan Designation	-
reducing body myopathy	Novantrone	Orphan Designation	-
secondary progressive multiple sclerosis	Novantrone	Orphan Designation	-
spermatogenic failure 81	Novantrone	Orphan Designation	-

← Back to Companies